Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

69041 B834(DE3) Competent Cells - Novagen

69041
Purchase on Sigma-Aldrich

Overview

Replacement Information

Products

Catalogue NumberPackaging Qty/Pack
69041-3CN Plastic ampoule 0.4 ml
69041-4CN Glass bottle 1 ml
Description
OverviewB834 is the parental strain for BL21 (1). These protease-deficient hosts are methionine auxotrophs and allow high specific-activity labeling of target proteins with 35S-methionine and selenomethionine for crystallography (2).

DE3 indicates that the host is a lysogen of λDE3, and therefore carries a chromosomal copy of the T7 RNA polymerase gene under control of the lacUV5 promoter. Such strains are suitable for production of protein from target genes cloned in pET vectors by induction with IPTG.



This product is sold for internal research use only. Any commercial use of this product, its components, and/or any derivatives thereof (including but not limited to proteins produced using the product or its components) (together and hereinafter the 'EMD Product') requires signature of a written commercial use agreement with EMD Millipore Corporation or its successor-in-interest. Commercial use shall include but not be limited to: (1) use of the EMD Product to manufacture products for sale to third parties; (2) use of the EMD Product to provide services, information, or data to third parties in exchange for consideration; (3) use of the EMD Product for therapeutic, diagnostic or prophylactic purposes (including as part of a device, chip, assay or other product); or (4) resale of the EMD Product, whether or not such EMD Product is resold for research use. Nothing contained herein shall be deemed to represent or warrant that additional third party rights are not required for use of the EMD Product. Please direct any questions on these use restrictions to: licensing@milliporesigma.com.
Genotype: F- ompT hsdSB(rB- mB-) gal dcm met (DE3)


This product contains genetically modified organisms (GMO). Within the EU GMOs are regulated by Directives 2001/18/EC and 2009/41/EC of the European Parliament and of the Council and their national implementation in the member States respectively. This legislation obliges MilliporeSigma to request certain information about you and the establishment where the GMOs are being handled. Click here for Enduser Declaration (EUD) Form.
Catalogue Number69041
Brand Family Novagen®
References
References1. Wood, W. B. (1966) J. Mol. Biol. 16, 118–133.

2. Leahy, D. J., Hendrickson, W. A., Aukhil, I., and Erickson, H. P. (1992) Science 258, 987–991.
Product Information
Components
Guaranteed efficiencyGuaranteed efficiency: > 2 x 10⁶ cfu/μg
Quality LevelMQ100
Applications
Biological Information
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Storage and Shipping Information
Ship Code Dry Ice Only
Toxicity Multiple Toxicity Values, refer to MSDS
Storage ≤ -70°C
Avoid freeze/thaw Avoid freeze/thaw
Do not freeze Ok to freeze
Packaging Information
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
69041-3CN 04055977259711
69041-4CN 04055977259728

Documentation

B834(DE3) Competent Cells - Novagen SDS

Title

Safety Data Sheet (SDS) 

B834(DE3) Competent Cells - Novagen Certificates of Analysis

TitleLot Number
69041

References

Reference overview
1. Wood, W. B. (1966) J. Mol. Biol. 16, 118–133.

2. Leahy, D. J., Hendrickson, W. A., Aukhil, I., and Erickson, H. P. (1992) Science 258, 987–991.

Brochure

Title
Competent Cell Brochure

Citations

Title
  • Rossi, F., et al. 2008. Journal of Biological Chemistry 283, 3559.
  • Xue, X., et al. 2008. Journal of Virology 82, 2515.
  • Buetow, L., et al. 2007. Procedings of the National Academy of Science 104, 4321.
  • Alderwick, L.J., et al. 2006. Proceedings of the National Academy of Sciences (USA) 103, 2558.
  • Chédin, F., et al. 2006. Journal of Biological Chemistry 281, 18610.
  • Sasaki, H.M., et al. 2006. Procedings of the National Academy of Science 103, 14744.
  • Sheckler, L.R., et al. 2006. Journal of Biological Chemistry 281, 22896.
  • Song, F., et al. 2006. Journal of Biological Chemistry 281, 11028.
  • Alphey, M.S., et al. 2005. Journal of Biological Chemistry 280, 3068.
  • Dey, S., et al. 2005. Journal of Biological Chemistry 280, 14892.
  • Maria- Eugenia Guazzaroni, M-F., et al. 2005. Journal of Biological Chemistry 280, 20887.
  • Jogl, G., et al. 2005. i>Journal of Biological Chemistry 280, 738.
  • Li, H., et al. 2005. Protein Science 14, 3025.
  • Li, K., et al. 2005. Journal of Biological Chemistry 280, 29176.
  • Singh, S., et al. 2005. Journal of Biological Chemistry 280, 17101.
  • Zhu, G., et al. 2005. Journal of Biological Chemistry 280, 23057.
  • Chen, Y-h., et al. 2004. Nature. 429, 675.
  • Hsieh, T-J., et al. 2004. Journal of Biological Chemistry 279, 55587.
  • Lehmann, C., et al. 2004. Proteins: Structure, Function, and Bioinformatics 56, 376.
  • Mancini, E.J., et al. 2004. Acta Crystallographica D60, 588.
  • Nguyen, H., et al. 2004. Journal of Structural and Functional Genomics 5, 23.
  • James S. Parker, S. Mark Roe and David Barford. 2004. European Molecular Biology Organization Journal 23, 4727.
  • Welin, M., et al. 2004. Procedings of the National Academy of Science 101, 17970.
  • Obmolova, G., et al. 2000. Nature 407, 703.
  • David K. Worthylake, Kent L. Rossman and John Sondek. 2000. Nature 408, 682.
  • Conn, G.L., et al. 1999. Science 284, 1171.
  • Joey M. Studts and Brian G, Fox. 1999. Protein Expression and Purification 16, 109.
  • Cabral, J.H.M., et al. 1998. Cell 95, 649.
  • Fauman, E.B., et al. 1998. Cell 93, 617.
  • Gomis-Ruth, F.-X., et al. 1997. Nature 389, 77.
  • Dyda, F., et al. 1994. Science 266, 1981.
  • User Protocols

    Title
    TB009 Competent Cells
    TB053 Academic and Non-profit Laboratory Assurance Letter